Home›Companies›Biotech & Pharma›Mekiri Bio

Mekiri Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 16, 2025·Suggest an edit

About Mekiri Bio

Mekiri Bio is a private company based in Boston, Massachusetts, incorporated in 2025 in Delaware. It has reported $1,000,000 raised in one offering on Form D since October 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 25, 2025Oct 16, 2025$1,000,000of $2.0M target1$1.0MSimple Agreement for Future EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Mekiri Bio's Form D filed Oct 16, 2025.

DL
Debbie Lin
President
AD
Anita DiFazio
Executive officer
AD
CM
Corey McCann
Director

Sources

  1. SECMekiri Bio, Inc. filing history